Clinical use of antimicrobial regional limb perfusion in horses: 174 cases (1999–2009)
| Autor: | Gabrielle Monteith, Belinda Black, Colette R. Elmas, Luis M. Rubio-Martínez |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Male
medicine.medical_specialty Lacerations Catheters Indwelling Synovitis Limb perfusion Animals Medicine Horses Intraosseous injection Adverse effect Survival rate Retrospective Studies General Veterinary business.industry Drug Administration Routes Horse Osteomyelitis Retrospective cohort study medicine.disease Anti-Bacterial Agents Surgery Etiology Female Horse Diseases business |
| Zdroj: | Journal of the American Veterinary Medical Association. 241:1650-1658 |
| ISSN: | 0003-1488 |
| DOI: | 10.2460/javma.241.12.1650 |
| Popis: | Objective—To describe the clinical use of regional limb perfusion with antimicrobials (A-RLP), complications, and outcome in a large series of patients. Design—Retrospective case series. Animals—174 horses. Procedures—Medical records of horses treated with A-RLP between 1999 and 2009 were reviewed. Signalment, primary complaint, horse use, etiology, duration of clinical signs, previous treatment, structures involved, concurrent conditions, A-RLP characteristics, additional treatments, complications, and outcome were recorded. At long-term follow-up, 2 outcomes were investigated: survival rate and return to previous use at the same or higher level. Univariate and multivariate logistic regression analyses were conducted. Results—Group 1 (96 horses) included septic synovitis. Group 2 (50 horses) included extrasynovial lacerations (23 horses) and fresh, minimally contaminated intrasynovial lacerations without evidence of established synovial infection (27 horses). Group 3 (28 horses) included miscellaneous other conditions. Only minor complications were reported in 12.26% of horses that received IV (n = 155) and 33% of horses that received intraosseous (27) A-RLP. Horses with septic synovitis had a lower survival rate (53.43%) than did horses with lacerations (91.89%). Within group 2, no significant differences in short- or long-term outcomes were found between horses with extrasynovial and fresh, minimally contaminated intrasynovial lacerations. For the horses returning to previous use, 80% of horses with septic synovitis and 72.72% of horses with lacerations were performing at the same or higher level at the time of follow-up. Conclusions and Clinical Relevance—The results of the present study indicated that A-RLP is a safe technique with minimal adverse effects. The IV route presented fewer complications than intraosseous injection. Horses with infection of synovial structures had a lower survival rate than did those with acute, minimally contaminated intrasynovial lacerations. The latter had a similar prognosis for horses with extrasynovial lacerations treated with A-RLP. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|